900
Participants
Start Date
April 1, 2025
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2028
Urine isoniazid testing (IsoScreen test)
Developed by Arkansas' Public Health Service in the 1970s, this test detects metabolites of isoniazid, a drug present in drug-susceptible TB regimens. IsoScreen (GFC Diagnostics, UK) is a commercial version of the Arkansas method with reagents enclosed in a plastic vial, into which 2mL of urine can be injected with a syringe. If the urine contains isoniazid, reagents turn purple/blue (suggesting a dose was taken in the last 24 hours or appropriate adherence) or green (suggesting a dose was taken 24-48 hours before or one missed dose). A yellow result (no color change) suggests medication has not been taken for \>48 hours (two or more missed doses).
Tuberculosis Research Centre, India
OTHER_GOV
Massachusetts General Hospital
OTHER
Tufts University
OTHER